Plain language summary and patient perspective of the European Society for Medical Oncology expert consensus statements on treating EGFR-positive non-small-cell lung cancer
Abstract
What is this summary about?
This article provides a plain language summary and patient perspective of a new set of recommendations made by the European Society for Medical Oncology (ESMO for short). These recommendations are also called expert consensus statements. They cover the management of people with a type of lung cancer called epidermal growth factor receptor-positive non-small-cell lung cancer (EGFR-positive NSCLC for short).
Why were the recommendations developed?
The ESMO Clinical Practice Guidelines are used by healthcare professionals when treating people with cancer, but they don't necessarily have all the information healthcare professionals need to make decisions for with people with EGFR-positive NSCLC. So, in 2021, 32 healthcare professionals who are experts in treating people with EGFR-positive NSCLC worked together to produce recommendations to fill these gaps about EGFR-positive NSCLC. This was called a consensus-building process and it also included patient advocates.
What recommendations did they make?
The experts discussed four main topics including how people with different stages of EGFR-positive NSCLC are diagnosed and treated, and how clinical studies are done. They reviewed the scientific information that exists on these subjects. They reached an agreement and developed the recommendations that are summarized here.
To read the full Plain Language Summary of this article, click here to view the PDF.
Link to original article here
https://www.annalsofoncology.org/article/S0923-7534(22)00112-0/fulltext
Acknowledgments
This article was selected by a Steering Committee, put together by the Future Science Group, who identified specific articles to be explained as a plain language summary to help educate about the latest developments in non-small cell lung cancer. The authors would like to thank the Steering Committee for their role in this selection process. Medical writing assistance was provided by Catherine Barras, MSc and Danielle Birchall, MRes MICR, of Simplifying Science® and was supported financially by Future Science Group, through an Independent Medical Education Grant provided by Pfizer, Inc. Simplifying Science® is a registered trademark in Great Britain and Northern Ireland. Trademark No. UK00003709258. Owned by and registered to Lay Writing Services Ltd.
Financial & competing interests disclosure
The Steering Committee were compensated for their time in the process of article selection as described above. The authors did not receive payment related to the development of the plain language summary of publication.
Open access
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/